arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CVS HEALTH Corp

CVS
$81.01 ▲ +1.05 (+1.31%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
20 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Bullish
auto_awesome

Analytical Summary

CVS HEALTH Corp shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $102.6B
Dividend Yield 3.28%
Revenue Growth 7.8% ↗
Op. Margin 1.2% ↘
ROIC 5.0% ↘
FCF / Share $6.16 ↗
Trailing P/E 57.9x
Price / Book 1.4x
FCF Yield 7.6%
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Nov 5, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$402.07B
↑ +7.8% —
Net Income Profit after all expenses
$1.77B
↓ -61.7% —
Operating Margin Operating profit as % of sales
1.2%
↓ -49.3% 31th
FCF / Share Free cash flow per share
$6.16
↑ +22.6% —
Long-Term Debt Long-term obligations
$73.43B
↑ +171.9% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
32
Returns ↓
48
Financial Health ↓
77
Cash Quality ↑
95

Dividend History

Dividend / share · sourced from SEC filings
$2.66 Latest / share
+0.0% YoY
+8.4% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 20 years · 75 quarters